{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T10:50:18Z","timestamp":1775645418530,"version":"3.50.1"},"reference-count":33,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,9]],"date-time":"2022-11-09T00:00:00Z","timestamp":1667952000000},"content-version":"vor","delay-in-days":1012,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["amjtransplant.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Transplantation"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1111\/ajt.15732","type":"journal-article","created":{"date-parts":[[2019,12,9]],"date-time":"2019-12-09T03:37:43Z","timestamp":1575862663000},"page":"362-376","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["C4 article: Challenges and solutions to appropriate and timely medication access in transplantation in the United States"],"prefix":"10.1016","volume":"20","member":"78","reference":[{"issue":"12","key":"10.1111\/ajt.15732_bib1","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.2215\/CJN.04220510","article-title":"Cost-related immunosuppressive medication nonadherence among kidney transplant recipients","volume":"5","author":"Evans","year":"2010","journal-title":"Clin J Am Soc Nephrol."},{"issue":"14","key":"10.1111\/ajt.15732_bib2","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.2146\/ajhp060634","article-title":"Effects of a medication assistance program with medication therapy management on the health of renal transplant recipients","volume":"64","author":"Chisholm","year":"2007","journal-title":"Am J Health Syst Pharm."},{"issue":"1","key":"10.1111\/ajt.15732_bib3","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1399-0012.2004.00114.x","article-title":"Increasing medication access to transplant recipients","volume":"18","author":"Chisholm","year":"2004","journal-title":"Clin Transplant."},{"issue":"17","key":"10.1111\/ajt.15732_bib4","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.2146\/ajhp040541","article-title":"Patient factors associated with adherence to immunosuppressant therapy in renal transplant recipients","volume":"62","author":"Chisholm","year":"2005","journal-title":"Am J Health Syst Pharm."},{"issue":"5","key":"10.1111\/ajt.15732_bib5","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1111\/j.1432-2277.2008.00827.x","article-title":"Medication-taking among adult renal transplant recipients: barriers and strategies","volume":"22","author":"Gordon","year":"2009","journal-title":"Transpl Int."},{"issue":"8","key":"10.1111\/ajt.15732_bib6","doi-asserted-by":"crossref","first-page":"e13627","DOI":"10.1111\/ctr.13627","article-title":"Discharge medication procurement and education after kidney transplantation","volume":"33","author":"Potter","year":"2019","journal-title":"Clin Transplant."},{"issue":"3","key":"10.1111\/ajt.15732_bib7","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1111\/ajt.12070","article-title":"Improving transplant patient safety through pharmacist discharge medication reconciliation","volume":"13","author":"Musgrave","year":"2013","journal-title":"Am J Transplant."},{"issue":"1","key":"10.1111\/ajt.15732_bib8","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1034\/j.1600-6143.2001.010113.x","article-title":"Effect of extended coverage of immunosuppressive medications by Medicare on the survival of cadaveric renal transplants","volume":"1","author":"Woodward","year":"2001","journal-title":"Am J Transplant."},{"issue":"10","key":"10.1111\/ajt.15732_bib9","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1111\/j.1600-6143.2004.00565.x","article-title":"Cost-effectiveness of extending Medicare coverage of immunosuppressive medications to the life of a kidney transplant","volume":"4","author":"Yen","year":"2004","journal-title":"Am J Transplant."},{"key":"10.1111\/ajt.15732_bib10","unstructured":"Department of Health and Human Services. Assessing the costs and benefits of extending coverage of immunosuppressive drugs under Medicare. 2019. https:\/\/aspe.hhs.gov\/pdf-report\/assessing-costs-and-benefits-extending-coverage-immunosuppressive-drugs-under-medicare.Accessed October 14, 2019."},{"issue":"4","key":"10.1111\/ajt.15732_bib11","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.cgh.2016.07.035","article-title":"Acute rejection increases risk of graft failure and death in recent liver transplant recipients","volume":"15","author":"Levitsky","year":"2017","journal-title":"Clin Gastroenterol Hepatol."},{"issue":"7","key":"10.1111\/ajt.15732_bib12","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1056\/NEJMp1114394","article-title":"Penny wise, pound foolish? Coverage limits on immunosuppression after kidney transplantation","volume":"366","author":"Gill","year":"2012","journal-title":"N Engl J Med."},{"issue":"7","key":"10.1111\/ajt.15732_bib13","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1111\/ajt.15293","article-title":"The association between loss of Medicare, immunosuppressive medication use, and kidney transplant outcomes","volume":"19","author":"Hart","year":"2019","journal-title":"Am J Transplant."},{"key":"10.1111\/ajt.15732_bib14","unstructured":"Organ Procurement and Transplantation Network. Pediatric transition and transfer guidance document. 2018. https:\/\/optn.transplant.hrsa.gov\/media\/2759\/pediatric_guidance_201812.pdf. Accessed October 14, 2019."},{"issue":"3","key":"10.1111\/ajt.15732_bib15","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1111\/ajt.13582","article-title":"Developing new immunosuppression for the next generation of transplant recipients: the path forward","volume":"16","author":"Stegall","year":"2016","journal-title":"Am J Transplant."},{"key":"10.1111\/ajt.15732_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev.med.59.090506.155819","article-title":"The FDA critical path initiative and its influence on new drug development","volume":"59","author":"Woodcock","year":"2008","journal-title":"Annu Rev Med."},{"key":"10.1111\/ajt.15732_bib17","series-title":"Advancing Regulatory Science at FDA","year":"2011"},{"issue":"6","key":"10.1111\/ajt.15732_bib18","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1111\/ajt.14703","article-title":"Transplant recipients are vulnerable to coverage denial under Medicare Part B","volume":"18","author":"Potter","year":"2018","journal-title":"Am J Transplant."},{"issue":"S4","key":"10.1111\/ajt.15732_bib19","first-page":"748","article-title":"Medicare Part D plans deny coverage for off-label and off-compendia immunosuppressant use: a case series","volume":"18","author":"Potter","year":"2018","journal-title":"Am J Transplant."},{"key":"10.1111\/ajt.15732_bib20","series-title":"Framework for FDA\u2019s Real-World Evidence Program","year":"2018"},{"issue":"5","key":"10.1111\/ajt.15732_bib21","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1111\/ajt.14222","article-title":"Proteasome inhibitor carfilzomib-based therapy for antibody-mediated rejection of the pulmonary allograft: use and short-term findings","volume":"17","author":"Ensor","year":"2017","journal-title":"Am J Transplant."},{"issue":"3","key":"10.1111\/ajt.15732_bib22","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/HCM.0000000000000220","article-title":"Examining the benefits of the 340b drug discount program","volume":"37","author":"Gerlach","year":"2018","journal-title":"Health Care Manag (Frederick)."},{"key":"10.1111\/ajt.15732_bib23","unstructured":"Food and Drug Administration. Drug Shortages. 2018. https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/drug-shortages.Accessed October 14, 2019."},{"issue":"21","key":"10.1111\/ajt.15732_bib24","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.2146\/ajhp180441","article-title":"ASHP guidelines on managing drug product shortages","volume":"75","author":"Fox","year":"2018","journal-title":"Am J Health Syst Pharm."},{"key":"10.1111\/ajt.15732_bib25","unstructured":"Wild D. Ohio pharmacists overhaul drug shortage strategy. ASHP Intersections. 2018. https:\/\/www.ashpintersections.org\/2018\/07\/ohio-pharmacists-overhaul-drug-shortage-strategy\/.Accessed October 14, 2019."},{"issue":"1","key":"10.1111\/ajt.15732_bib26","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.1600-6143.2012.04308.x","article-title":"Disruptions in the supply of medications used in transplantation: implications and management strategies for the transplant clinician","volume":"13","author":"Krisl","year":"2013","journal-title":"Am J Transplant."},{"issue":"2","key":"10.1111\/ajt.15732_bib27","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/j.1600-6143.2011.03840.x","article-title":"Understanding the causes of kidney transplant failure: the dominant role of antibody-mediated rejection and nonadherence","volume":"12","author":"Sellar\u00e9s","year":"2012","journal-title":"Am J Transplant."},{"issue":"3","key":"10.1111\/ajt.15732_bib28","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1111\/ajt.14635","article-title":"Meeting report: FDA public meeting on patient-focused drug development and medication adherence in solid organ transplant patients","volume":"18","author":"Ettenger","year":"2018","journal-title":"Am J Transplant."},{"key":"10.1111\/ajt.15732_bib29","first-page":"27","article-title":"Patient survey to identify reasons for non-adherence and elicitation of quality of life concepts associated with immunosuppressant therapy in kidney transplant recipients","volume":"10","author":"Muduma","year":"2016","journal-title":"Patient Prefer Adherence."},{"issue":"1","key":"10.1111\/ajt.15732_bib30","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s12160-012-9359-4","article-title":"Non-adherence to immunosuppressive medications in kidney transplantation: intent vs. forgetfulness and clinical markers of medication intake","volume":"44","author":"Griva","year":"2012","journal-title":"Ann Behav Med."},{"issue":"2","key":"10.1111\/ajt.15732_bib31","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1331\/JAPhA.2013.12202","article-title":"Smartphone medication adherence apps: potential benefits to patients and providers","volume":"53","author":"Dayer","year":"2013","journal-title":"J Am Pharm Assoc."},{"issue":"5","key":"10.1111\/ajt.15732_bib32","doi-asserted-by":"crossref","first-page":"e844","DOI":"10.1542\/peds.2009-0415","article-title":"Improved adherence and outcomes for pediatric liver transplant recipients by using text messaging","volume":"124","author":"Miloh","year":"2009","journal-title":"Pediatrics."},{"issue":"1","key":"10.1111\/ajt.15732_bib33","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.2196\/jmir.2284","article-title":"Patient attitudes toward mobile phone-based health monitoring: questionnaire study among kidney transplant recipients","volume":"15","author":"McGillicuddy","year":"2013","journal-title":"J Med Internet Res."}],"container-title":["American Journal of Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fajt.15732","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ajt.15732","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/ajt.15732","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522221893?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522221893?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ajt.15732","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:28:27Z","timestamp":1761629307000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1600613522221893"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["S1600613522221893"],"URL":"https:\/\/doi.org\/10.1111\/ajt.15732","relation":{},"ISSN":["1600-6135"],"issn-type":[{"value":"1600-6135","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"C4 article: Challenges and solutions to appropriate and timely medication access in transplantation in the United States","name":"articletitle","label":"Article Title"},{"value":"American Journal of Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/ajt.15732","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2020 American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. All rights reserved. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}